Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

Sep 11, 2017

30786_dirs_2017-09-11_695e44c8-4c5d-4c8a-8d13-ae5dd2a3ec6a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-07

Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-07 Bio-Rad A Common Stock M 600 Acquired 2660 Direct
2017-09-07 Bio-Rad A Common Stock F 226 $215.44 Disposed 2434 Direct
2017-09-10 Bio-Rad A Common Stock M 389 Acquired 2823 Direct
2017-09-10 Bio-Rad A Common Stock F 147 $218.42 Disposed 2676 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-07 Restricted Stock Units $0 M 600 Disposed Bio-Rad A Common Stock (600) Direct
2017-09-10 Restricted Stock Units $0 M 389 Disposed Bio-Rad A Common Stock (389) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 7, 2017.

F4: The restricted stock units vest in five equal annual installments beginning September 10, 2015.